Australian Clinical Labs (ASX:ACL) Interest Expense : A$-4.5 Mil (TTM As of Dec. 2024)

View and export this data going back to 2021. Start your Free Trial

What is Australian Clinical Labs Interest Expense?

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Australian Clinical Labs's interest expense for the six months ended in Dec. 2024 was A$ -2.1 Mil. Its interest expense for the trailing twelve months (TTM) ended in Dec. 2024 was A$-4.5 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Australian Clinical Labs's Operating Income for the six months ended in Dec. 2024 was A$ 28.4 Mil. Australian Clinical Labs's Interest Expense for the six months ended in Dec. 2024 was A$ -2.1 Mil. Australian Clinical Labs's Interest Coverage for the quarter that ended in Dec. 2024 was 13.52. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Australian Clinical Labs Interest Expense Historical Data

The historical data trend for Australian Clinical Labs's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Australian Clinical Labs Interest Expense Chart

Australian Clinical Labs Annual Data

Trend

Dec20

Jun21

Jun22

Jun23

Jun24

Interest Expense

-10.94

-1.34

-3.54

-4.86

Australian Clinical Labs Semi-Annual Data
	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24
Interest Expense	Get a 7-Day Free Trial				-1.15	-2.39	-2.43	-2.43	-2.10

Australian Clinical Labs Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Dec. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was A$-4.5 Mil.

Australian Clinical Labs (ASX:ACL) Interest Expense Explanation

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Australian Clinical Labs's Interest Expense for the six months ended in Dec. 2024 was A$-2.1 Mil. Its Operating Income for the six months ended in Dec. 2024 was A$28.4 Mil. And its Long-Term Debt & Capital Lease Obligation for the six months ended in Dec. 2024 was A$204.6 Mil.

Australian Clinical Labs's Interest Coverage for the quarter that ended in Dec. 2024 is calculated as

Interest Coverage	=	-1	*	Operating Income (Q: Dec. 2024 )	/	Interest Expense (Q: Dec. 2024 )
	=	-1	*	28.351	/	-2.097
	=	13.52

The higher the ratio, the stronger the company's financial strength is.

Australian Clinical Labs Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Australian Clinical Labs Ltd (ASX:ACL) » Definitions » Interest Expense

Comparable Companies

Traded in Other Exchanges

N/A

Address

1868-1892 Dandenong Road, Clayton, VIC, AUS, 3168

Website

https://www.clinicallabs.com.au

Australian Clinical Labs is Australia's third-largest private pathology provider. ACL earns almost its entire group revenue from pathology services in Australia, which are mostly earned via the publicly funded health Medicare system. ACL is well established in the states of Western Australia, South Australia, Victoria, and the Northern Territory.

Australian Clinical Labs Headlines

No Headlines